1. Home
  2. GASS vs ENTA Comparison

GASS vs ENTA Comparison

Compare GASS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

HOLD

Current Price

$9.11

Market Cap

345.6M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.51

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GASS
ENTA
Founded
2004
1995
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.6M
374.6M
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
GASS
ENTA
Price
$9.11
$12.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
242.8K
170.9K
Earning Date
03-02-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.93
EPS
N/A
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
N/A
N/A
P/E Ratio
$5.00
N/A
Revenue Growth
N/A
16.48
52 Week Low
$4.90
$4.09
52 Week High
$10.52
$17.15

Technical Indicators

Market Signals
Indicator
GASS
ENTA
Relative Strength Index (RSI) 52.03 40.63
Support Level $8.67 $12.09
Resistance Level $10.52 $15.52
Average True Range (ATR) 0.46 0.81
MACD -0.08 -0.17
Stochastic Oscillator 29.19 2.50

Price Performance

Historical Comparison
GASS
ENTA

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: